Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease
A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development.
AbboMax has been involved in researching, developing and manufacturing of high performance antibodies and related immunoassay reagents for many years. Abbomax specializes in antibody and assay development, provides high-quality custom service and products. AbboMax is focusing on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services including recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), scale-up process for pharmaceutical companies and CLIA labs. All the manufacturing activities are performed in the Silicon Valley Core Facility located in San Jose, California. Abbomax can provide bulk quantities at economical prices, and guarantee a fast delivery with high quality products.
Contact: Natasha Raysberg, Ph.D.
Phone 408-573-1898, Fax 408-573-1858